Lataa...
The effect of Bortezomib and Rapamycin on Telomerase Activity in Mantle Cell Lymphoma
Mantle cell lymphoma (MCL) is a hematological malignancy with unfavorable prognosis. Novel therapeutic approaches for treating the disease are aimed at the mechanisms regulating growth signals, cellular proliferation, and survival pathways of the malignant clones. Bortezomib (Brt), a proteasome inhi...
Tallennettuna:
| Julkaisussa: | Transl Oncol |
|---|---|
| Päätekijät: | , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Neoplasia Press
2014
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4311042/ https://ncbi.nlm.nih.gov/pubmed/25500084 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tranon.2014.09.004 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|